VaRi Bioscience

VaRi Bioscience is a clinical-stage biotechnology company based in Germany, specializing in the development of innovative drug delivery systems for women's health. The company's core technology is the VaRi-Ring, a proprietary intravaginal ring platform designed for the controlled, long-term release of hormones and other active ingredients. Their lead candidate, VAR-101, is being developed for indications such as contraception and hormone replacement therapy, aiming to improve patient compliance and reduce side effects compared to oral alternatives. VaRi Bioscience focuses on addressing unmet needs in gynecology through localized and sustained-release therapeutic solutions.